Imperial Brands has agreed a research and development partnership with Auxly Cannabis Group, a Canadian company.
The FTSE 100 tobacco manufacturer will invest £75 million via a three-year debenture, which can be converted into a near 20 per cent equity stake at any time. It has granted Auxly global licences to Imperial’s vaping technology and access to Nerudia, its innovation business based in Liverpool.
